Outcome of “treat and monitor” regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion
Conclusion“Treat and monitor” regimen is a real-life effective strategy in improving visual acuity after macular edema from branch vein occlusion and in reducing the number of injections.
Source: International Ophthalmology - Category: Opthalmology Source Type: research
More News: Angiography | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Statistics | Vitamin A